Protheos
Protheos, a leading player in the biotechnology sector, is headquartered in France and operates extensively across Europe. Founded in 2015, the company has rapidly established itself as a pioneer in the development of innovative biopharmaceutical solutions, focusing on advanced therapies and personalised medicine. Protheos is renowned for its unique approach to drug development, leveraging cutting-edge technologies to enhance therapeutic efficacy and patient outcomes. With a commitment to research and development, the company has achieved significant milestones, including collaborations with major pharmaceutical firms and successful clinical trials. As a trusted name in the industry, Protheos continues to push the boundaries of biotechnology, positioning itself at the forefront of medical advancements and contributing to the evolution of healthcare solutions.
DitchCarbon Score
How does Protheos's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Protheos's score of 26 is higher than 50% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Protheos's reported carbon emissions
In 2024, Protheos reported total carbon emissions of approximately 124,700 kg CO2e, comprising 1,100 kg CO2e from Scope 1, 1,800 kg CO2e from Scope 2, and a significant 121,800 kg CO2e from Scope 3 emissions. This data reflects a slight increase from 2022, when total emissions were about 128,000 kg CO2e, with similar contributions from Scope 1 (1,100 kg CO2e), Scope 2 (2,200 kg CO2e), and Scope 3 (124,700 kg CO2e). Protheos has set a near-term reduction target for Scope 2 emissions, aiming for a 20% decrease by 2028, projecting emissions to fall to 1,200 kg CO2e. This commitment underscores the company's proactive approach to mitigating its carbon footprint. The emissions data is not cascaded from any parent organization, indicating that Protheos independently reports its carbon emissions and climate commitments. The company continues to focus on enhancing its sustainability practices in alignment with industry standards.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Protheos is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
